Anika Therapeutics Incorporated

Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products and devices intended to repair, protect and heal bone, cartilage and soft tissues. These products are currently derived from hyaluronic acid ("HA"), a naturally-occurring, biocompatible polymer found throughout the body. As suggested in the literature, the unique biophysical and biochemical properties of HA appear to play an important role in a number of physiological functions such as the protection, coating and lubrication of soft tissues and joints, the maintenance of the structural integrity of tissues, and the transport of molecules to specific anatomical sites.

Contact Details: 160 New Boston Street Woburn 01801 United States of America Tel: 935 932 6616 Fax: 781 935 4120 Email: WWW: www.anikatherapeutics.com/

BioNews Results for Anika Therapeutics Incorporated:
Anika Therapeutics Announces Exclusive Canadian Distribution Agreement for ELEVESS(R) with Canderm Pharma Inc	SmartBrief:  Oct 5 2008 5:39AM Matching: anika therapeutics
Anika signs distribution agreement with Canderm Pharma	Datamonitor:  Oct 4 2008 1:31AM Matching: anika therapeutics
Anika Therapeutics Announces Exclusive Canadian Distribution Agreement for ELEVESS with Canderm Pharma Inc	Pharma Live:  Oct 3 2008 6:15AM Matching: anika therapeutics
Anika Therapeutics Announces Exclusive Canadian Distribution Agreement for ELEVESS(R) with Canderm Pharma Inc	DiGiTAL50:  Oct 2 2008 9:36PM Matching: anika therapeutics
Anika Therapeutics Announces Exclusive Canadian Distribution Agreement for ELEVESS(R) with Canderm Pharma Inc	PR inside:  Oct 2 2008 3:08PM Matching: anika therapeutics
Promote your company here: BioNewsCast - Press Release Distribution	→View more Anika Therapeutics Incorporated news.

Anika Therapeutics Incorporated Patents:
US Patent No.	Title
6884788	Thiol-modified hyaluronan
6620927	Thiol-modified hyaluronan
6548081	Bioabsorbable composites of derivatized hyaluronic acid and other biodegradable, biocompatible polymers
6537979	Water-insoluble derivatives of hyaluronic acid crosslinked with a biscarbodiimide
6096727	Method for treating wounds using modified hyaluronic acid crosslinked with biscarbodiimide
→View more Anika Therapeutics Incorporated patents.

Anika Therapeutics Incorporated (ANIK) Financial information Links from Barchart
ANIK Quote from from Barchart.com
ANIK Chart from from Barchart.com
ANIK Profile from from Barchart.com
ANIK Opinion from from Barchart.com
→View more Anika Therapeutics Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 274 times since April 2007, the link to the organisation's website has been followed 47 times

Recent Search Terms used to find this page: Anika biscarbodiimide | anika therapeutics | anika therapeutics | Anika Therapeutics Hyaluronic | Anika Therapeutics Incorporated | hyaluronic | anika therapeutics hyaluronic acid | Anika Therapeutics indeed | Anika biscarbodiimide | anika therapeutics incorporated website | .

Search for more companies in Woburn

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Anika Therapeutics Incorporated